Gilead shares fall after mixed results, as weaker COVID-19 drug remand weighs
Gilead Sciences Inc. on Thursday cut one of its profit forecasts and reported first-quarter profit that missed expectations, with weaker ...
Read moreTag: GILD
- Trending
- Comments
- Latest
